{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:30:01Z","timestamp":1791462601838,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ymgme.2012.05.004","type":"journal-article","created":{"date-parts":[[2012,5,14]],"date-time":"2012-05-14T07:50:26Z","timestamp":1336981826000},"page":"287-300","source":"Crossref","is-referenced-by-count":24,"title":["Transcriptional response to GAA deficiency (Pompe disease) in infantile-onset patients"],"prefix":"10.1016","volume":"106","author":[{"given":"A.T.","family":"Palermo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.E.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.S.","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.M.","family":"Oba-Shinjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.T.","family":"Madhiwalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.F.","family":"Finn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.M.","family":"Ciociola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pescatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"McVie-Wylie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Mattaliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.K.N.","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.W.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Pomponio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2012.05.004_bb0005","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. [Review] [111 refs]","volume":"112","author":"Van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0020","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe's disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/ana.410380316","article-title":"Genotype\u2013phenotype correlation in adult-onset acid maltase deficiency","volume":"38","author":"Wokke","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0030","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","article-title":"Juvenile and adult-onset acid maltase deficiency in France: genotype\u2013phenotype correlation","volume":"55","author":"Laforet","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T->G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ejhg.2008.34","article-title":"p.[G576S; E689K]: pathogenic combination or polymorphism in Pompe disease?","volume":"16","author":"Kroos","year":"2008","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ymgme.2009.12.014","article-title":"Genetic heterozygosity and pseudodeficiency in the Pompe disease newborn screening pilot program","volume":"99","author":"Labrousse","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0050","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10038-007-0191-9","article-title":"Structural and biochemical studies on Pompe disease and a \u201cpseudodeficiency of acid alpha-glucosidase\u201d","volume":"52","author":"Tajima","year":"2007","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0055","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe's disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0065","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jpeds.2010.11.053","article-title":"Later-onset Pompe disease: early detection and early treatment initiation enabled by newborn screening","volume":"158","author":"Chien","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0075","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nmd.2006.09.004","article-title":"Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations","volume":"17","author":"Palmer","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0085","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00415-009-5219-y","article-title":"Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations","volume":"256","author":"Oba-Shinjo","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0090","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0095","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1073\/pnas.0401736101","article-title":"Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes","volume":"101","author":"Pittman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0100","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Statist. Soc."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0110","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/brain\/awl023","article-title":"Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration","volume":"129","author":"Bakay","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0115","doi-asserted-by":"crossref","first-page":"30091","DOI":"10.1074\/jbc.M202668200","article-title":"Slug is a novel downstream target of MyoD. Temporal profiling in muscle regeneration","volume":"277","author":"Zhao","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiolgenomics.00045.2008","article-title":"Characterization of the acute temporal changes in excisional murine cutaneous wound inflammation by screening of the wound-edge transcriptome","volume":"34","author":"Roy","year":"2008","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0125","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1089\/neu.2008.0676","article-title":"Closed head injury in a mouse model results in molecular changes indicating inflammatory responses","volume":"26","author":"Israelsson","year":"2009","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1146\/annurev-physiol-012110-142250","article-title":"Role of chitin and chitinase\/chitinase-like proteins in inflammation, tissue remodeling, and injury","volume":"73","author":"Lee","year":"2011","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0135","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1042\/BST0390989","article-title":"Old and new findings on lipopolysaccharide-binding protein: a soluble pattern-recognition molecule","volume":"39","author":"Schumann","year":"2011","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0140","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1101\/gad.10.9.1054","article-title":"p53: puzzle and paradigm","volume":"10","author":"Ko","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0145","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1101\/gad.14.6.704","article-title":"PERP, an apoptosis-associated target of p53, is a novel member of the PMP-22\/gas3 family","volume":"14","author":"Attardi","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0150","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1038\/sj.onc.1209225","article-title":"Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas","volume":"25","author":"Machida","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1432-0436.2006.00060.x","article-title":"The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing","volume":"74","author":"Pascual","year":"2006","journal-title":"Differentiation"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10048-003-0148-x","article-title":"Gene expression profiling of Duchenne muscular dystrophy skeletal muscle","volume":"4","author":"Haslett","year":"2003","journal-title":"Neurogenetics"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0165","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/gim.2011.4","article-title":"Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease","volume":"14","author":"Messinger","year":"2012","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1365-2249.2008.03602.x","article-title":"Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model","volume":"152","author":"Joseph","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0175","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1056\/NEJMc0806809","article-title":"Elimination of antibodies to recombinant enzyme in Pompe's disease","volume":"360","author":"Mendelsohn","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gde.2008.01.018","article-title":"Utilization of genomic signatures to direct use of primary chemotherapy","volume":"18","author":"Potti","year":"2008","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0185","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1158\/1078-0432.CCR-10-2703","article-title":"A five-gene and corresponding protein signature for stage-I lung adenocarcinoma prognosis","volume":"17","author":"Kadara","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1158\/1078-0432.CCR-10-1126","article-title":"A 4-gene signature associated with clinical outcome in high-grade gliomas","volume":"17","author":"de Tayrac","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0195","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1158\/1078-0432.CCR-10-1265","article-title":"Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin, and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer","volume":"16","author":"Tabchy","year":"2010","journal-title":"Clin. Cancer Res."},{"issue":"Suppl. 1","key":"10.1016\/j.ymgme.2012.05.004_bb0200","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1016\/S0960-8966(02)00093-7","article-title":"A web-accessible complete transcriptome of normal human and DMD muscle","volume":"12","author":"Bakay","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0205","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.ymgme.2004.06.020","article-title":"Global gene expression in a type 2 Gaucher disease brain","volume":"83","author":"Myerowitz","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-1-59745-447-6_7","article-title":"YKL-40: a novel marker shared by chronic inflammation and oncogenic transformation","volume":"511","author":"Roslind","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0215","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00129039-200106000-00001","article-title":"CD79: a review","volume":"9","author":"Chu","year":"2001","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0220","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1023\/A:1026127307457","article-title":"Satellite cell depletion in degenerative skeletal muscle","volume":"8","author":"Jejurikar","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0225","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.cellbio.12.1.417","article-title":"The mammalian myosin heavy chain gene family","volume":"12","author":"Weiss","year":"1996","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0230","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/MCB.8.12.5257","article-title":"Stepwise activation of the mouse acetylcholine receptor delta- and gamma-subunit genes in clonal cell lines","volume":"8","author":"Crowder","year":"1988","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0235","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1074\/jbc.M507440200","article-title":"Fgfr4 is required for effective muscle regeneration in vivo. Delineation of a MyoD-Tead2-Fgfr4 transcriptional pathway","volume":"281","author":"Zhao","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0240","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jmb.2003.09.012","article-title":"The muscle ankyrin repeat proteins: CARP, ankrd2\/Arpp and DARP as a family of titin filament-based stress response molecules","volume":"333","author":"Miller","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0245","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1152\/japplphysiol.01046.2004","article-title":"Expression of Ankrd2 in fast and slow muscles and its response to stretch are consistent with a role in slow muscle function","volume":"98","author":"McKoy","year":"2005","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0250","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1742-4658.2008.06814.x","article-title":"Cardiac ankyrin repeat protein is a marker of skeletal muscle pathological remodelling","volume":"276","author":"Laure","year":"2009","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0255","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1111\/j.1742-4658.2010.07820.x","article-title":"A new pathway encompassing calpain 3 and its newly identified substrate cardiac ankyrin repeat protein is involved in the regulation of the nuclear factor-kappaB pathway in skeletal muscle","volume":"277","author":"Laure","year":"2010","journal-title":"FEBS J."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0260","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0002-9440(10)63188-4","article-title":"Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis","volume":"164","author":"Li","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0265","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0270","doi-asserted-by":"crossref","first-page":"C834","DOI":"10.1152\/ajpcell.00579.2003","article-title":"The molecular basis of skeletal muscle atrophy","volume":"287","author":"Jackman","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0275","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1172\/JCI2131","article-title":"Altered wound healing in mice lacking a functional osteopontin gene","volume":"101","author":"Liaw","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0280","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2121-7-38","article-title":"Nuclear envelope transmembrane proteins (NETs) that are up-regulated during myogenesis","volume":"7","author":"Chen","year":"2006","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0285","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1096\/fj.09-129833","article-title":"Imatinib attenuates skeletal muscle dystrophy in mdx mice","volume":"23","author":"Huang","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0290","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1016-8478(23)17614-X","article-title":"Curcumin alleviates dystrophic muscle pathology in mdx mice","volume":"25","author":"Pan","year":"2008","journal-title":"Mol. Cells"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0295","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nmd.2007.11.002","article-title":"Reduced muscle necrosis and long-term benefits in dystrophic mdx mice after cV1q (blockade of TNF) treatment","volume":"18","author":"Radley","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0300","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.expneurol.2005.11.021","article-title":"Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice","volume":"198","author":"Messina","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ymgme.2012.05.004_bb0305","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/mus.10431","article-title":"Ventilatory dysfunction in mdx mice: impact of tumor necrosis factor-alpha deletion","volume":"28","author":"Gosselin","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2012.05.004_bb0310","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1189\/jlb.0905530","article-title":"TNF induces distinct gene expression programs in microvascular and macrovascular human endothelial cells","volume":"80","author":"Viemann","year":"2006","journal-title":"J. Leukoc. Biol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921200193X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109671921200193X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T14:54:14Z","timestamp":1713970454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109671921200193X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S109671921200193X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2012.05.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}